PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Biotech
CETP Inhibitors: Blockbusters that Never Ran?
The news that Roche scrapped development on its CETP inhibitor dalcetrapib, a drug designed to raise HDL cholesterol in the blood, likely presages the shuttering of Lilly’s development program for its CETP inhibitor, evacetrapib, industry experts and analysts say.
Posted in Biotech, R&D, Technology, leadership Also tagged Biotechnology and Pharmaceuticals, Cardiovascular disease, CETP Inhibitors, Lilly, Merck, Resverlogix, Roche Leave a comment
Uncertain Outlook for Pharma and Biotech Deals Following 'Turbulent' 2011
Peter Young, President and Managing Director of international investment bank Young & Partners, looks at what lies ahead for pharma and biotech following a turbulent 2011.
The business outlook for pharma companies for the rest of 2012 and beyond is mixed, as pharma companies struggle to realign themselves to a new business model that will work. [...]
Posted in Global, Guest Blog, Strategy, leadership Also tagged 2011, M&A, Pharma, pipelines, Young & Partners Leave a comment
VC Funding Floods Colorado Biotechs, But Will It Stifle Innovation?
By Marylyn Donahue.
Biotechs in Colorado, US, are enjoying a windfall of funding from Venture Capitalists who have to date invested $66.1 million in six of the state’s companies working in the fields of biofuel, medical devices and biopharma, according to a report released Feb 21 by OnBioVC, a Boulder-based tracker of investments in the life [...]
Posted in Biotech, Deals, Guest Blog Also tagged Biogen, Colorado, funding, OnBioVC, Stewart Lyman, VC, venture capitalists Leave a comment
Shrinking Economy Hits California Biosector
By Amy Ritter, Pharmaeutical Technology.
A report released on Feb. 8, 2012 from the California Healthcare Institute, BayBio and PwC shows that the shrinking economy, changes in investment strategies, and pressures on the pharmaceutical market have put the brakes on one of the US’s most robust biotechnology centers. California had enjoyed steady growth in its biotech [...]
Posted in Biotech, Guest Blog Also tagged BayBio, biopharmaceuticals, California Healthcare Institute, economy Leave a comment
New York Pharma Forum: Together We Stand